Chemours Shares Up 3.8% as Valuation Signals Possible Undervaluation
GF Score™ of 67/100 suggests The Chemours Co may be above-average, with the stock trading at $15.68 versus a GF Value™ estimate of $18.92, implying about 17.1% undervaluation. Forward P/E is 8.1x below a 5-year median of 10.1x. Insider buying is viewed as positive, but caution is warranted due to cash-flow negativity and lack of a trailing P/E from unprofitability.